We are live on
!
Find out more
MRCM
M&R Capital Management Portfolio holdings
AUM
$454M
1-Year Est. Return
40.11%
This Fund
S&P 500
This Quarter
Est. Return
+4.69%
1 Year Est. Return
+40.11%
3 Year Est. Return
+52.56%
5 Year Est. Return
+141.03%
10 Year Est. Return
+275.44%
AUM
$346M
AUM Growth
-$15.8M
(-4.4%)
Cap. Flow
-$25.8M
Cap. Flow
% of AUM
-7.44%
Top 10 Holdings %
Top 10 Hldgs %
29.64%
Holding
199
New
8
Increased
68
Reduced
64
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FedEx
FDX
|
+$4.61M |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.12M |
| 3 |
ExxonMobil
XOM
|
+$1.03M |
| 4 |
Church & Dwight Co
CHD
|
+$874K |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$856K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$6.5M |
| 2 |
Aflac
AFL
|
+$5.32M |
| 3 |
BID
Sotheby's
BID
|
+$4.42M |
| 4 |
Visa
V
|
+$4.26M |
| 5 |
Qualcomm
QCOM
|
+$3.39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.55% |
| 2 | Healthcare | 17.17% |
| 3 | Miscellaneous | 14.85% |
| 4 | Communication Services | 13.98% |
| 5 | Industrials | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MWR.CL
26
DELISTED
MORGAN STANLEY CAPITAL TRUST III
MWR.CL
| $4.16M | 1.2% |
163,295
-225
| -0.1% | -$5.75K |
|
27
BlackRock Credit Allocation Income Trust
BTZ
$946M
| $4.13M | 1.19% |
334,245
-20,400
| -6% | -$251K |
|
|
28
Meta Platforms (Facebook)
META
$1.47T
| $4.01M | 1.16% |
38,365
+30,390
| +381% | +$3.12M |
|
29
GE Aerospace
GE
$355B
| $3.93M | 1.13% |
26,305
+4,868
| +23% | +$691K |
|
30
Pfizer
PFE
$159B
| $3.63M | 1.05% |
118,629
+8,459
| +8% | +$266K |
|
31
Microsoft
MSFT
$3.81T
| $3.5M | 1.01% |
63,158
+2,600
| +4% | +$137K |
|
32
Colgate-Palmolive
CL
$72.3B
| $3.41M | 0.99% |
51,225
-884
| -2% | -$58.8K |
|
33
State Street
STT
$53.1B
| $3.39M | 0.98% |
51,109
-2,049
| -4% | -$142K |
|
|
CSI
34
DELISTED
Cutwater Select Income Fund
CSI
| $3.22M | 0.93% |
176,100
-12,500
| -7% | -$236K |
|
35
Procter & Gamble
PG
$334B
| $3.13M | 0.9% |
39,359
+515
| +1% | +$39.4K |
|
36
Henry Schein
HSIC
$9.98B
| $3.08M | 0.89% |
49,608
-1,402
| -3% | -$83.4K |
|
|
37
Qualcomm
QCOM
$175B
| $2.77M | 0.8% |
55,505
-63,593
| -53% | -$3.39M |
|
38
Wells Fargo
WFC
$262B
| $2.69M | 0.78% |
49,534
+117
| +0.2% | +$6.35K |
|
39
CVS Health
CVS
$119B
| $2.65M | 0.76% |
27,096
+350
| +1% | +$34.3K |
|
40
IBM
IBM
$222B
| $2.6M | 0.75% |
19,777
+562
| +3% | +$75.5K |
|
41
BP
BP
$109B
| $2.43M | 0.7% |
92,346
-41,890
| -31% | -$1.19M |
|
42
SLB Ltd
SLB
$85.1B
| $2.18M | 0.63% |
31,296
-863
| -3% | -$64.6K |
|
43
Merck
MRK
$366B
| $2.04M | 0.59% |
40,433
+7,765
| +24% | +$391K |
|
44
Sabesp
SBS
$17.1B
| $2.04M | 0.59% |
2,283,313
-259,270
| -10% | -$233K |
|
45
Verizon
VZ
$208B
| $2.03M | 0.59% |
44,015
+809
| +2% | +$36.7K |
|
46
Chevron
CVX
$396B
| $2M | 0.58% |
22,227
-44
| -0.2% | -$3.97K |
|
47
Bristol-Myers Squibb
BMY
$136B
| $1.98M | 0.57% |
28,706
+1,553
| +6% | +$103K |
|
48
Waste Management
WM
$87.8B
| $1.9M | 0.55% |
35,624
-2,075
| -6% | -$110K |
|
49
AbbVie
ABBV
$451B
| $1.71M | 0.49% |
28,894
+2,620
| +10% | +$151K |
|
50
iShares Biotechnology ETF
IBB
$10.5B
| $1.57M | 0.45% |
13,935
+750
| +6% | +$81.4K |
|
Similar funds
EDRIA
SFP
AC
NIC
WCA
KC
SIGI
FPFS
M&R Capital Management's Q4 2015 Portfolio in Review
As of Q4 2015, M&R Capital Management held 199 positions worth $346M, down 4.4% from $362M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
M&R Capital Management withdrew a net $25.8M in Q4 2015, closing 11 positions and reducing 64 holdings. Its most notable exit was Sotheby's, an estimated $4.42M position sold in full.
By sector, the portfolio is most concentrated in Financials at 18% of assets, down from 19% a quarter earlier, followed by Healthcare and Miscellaneous.
Against the trend, M&R Capital Management opened a new position in Hershey worth $279K.
- M&R Capital Management's largest Q4 2015 buy was Hershey: 3,130 shares worth $279K.
- M&R Capital Management added most to FedEx in Q4 2015, an estimated $4.61M increase.
- M&R Capital Management's biggest Q4 2015 reduction was Allergan plc, cutting an estimated $6.5M.
- M&R Capital Management fully exited Sotheby's in Q4 2015, selling an estimated $4.42M.
- M&R Capital Management's ten largest holdings make up 30% of its $346M portfolio in Q4 2015.
- M&R Capital Management opened 8 new positions and closed 11 in Q4 2015.
- M&R Capital Management's portfolio value fell 4.4% quarter-over-quarter to $346M.
Based on M&R Capital Management's 13F filing for Q4 2015, filed 11 Feb 2016.